Gossamer Bio Inc (NASDAQ: GOSS) closed the day trading at $1.35 up 2.27% from the previous closing price of $1.32. In other words, the price has increased by $+0.0300 from its previous closing price. On the day, 1088757 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a better understanding of GOSS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.94 and its Current Ratio is at 5.94. In the meantime, Its Debt-to-Equity ratio is 3.38 whereas as Long-Term Debt/Eq ratio is at 3.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on July 27, 2023, Downgraded its rating to Neutral and sets its target price to $1.25 from $8 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 18 ’24 when Peterson Caryn sold 4,018 shares for $1.33 per share. The transaction valued at 5,343 led to the insider holds 49,833 shares of the business.
Aranda Richard sold 4,018 shares of GOSS for $5,342 on Mar 18 ’24. The Chief Medical Officer now owns 198,799 shares after completing the transaction at $1.33 per share. On Nov 15 ’23, another insider, Milligan Sandra, who serves as the Director of the company, bought 32,000 shares for $0.79 each. As a result, the insider paid 25,213 and bolstered with 32,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GOSS now has a Market Capitalization of 304.54M and an Enterprise Value of 220.58M.
Stock Price History:
Over the past 52 weeks, GOSS has reached a high of $1.88, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is 1.1117, while the 200-Day Moving Average is calculated to be 1.0159.
Shares Statistics:
Over the past 3-months, GOSS traded about 1.07M shares per day on average, while over the past 10 days, GOSS traded about 1.52M shares per day. A total of 225.41M shares are outstanding, with a floating share count of 188.82M. Insiders hold about 16.30% of the company’s shares, while institutions hold 79.44% stake in the company. Shares short for GOSS as of Feb 29, 2024 were 14.3M with a Short Ratio of 13.32, compared to 16.72M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.34% and a Short% of Float of 7.45%.
Earnings Estimates
Current recommendations for the stock of the company come from 9 analysts. On average, analysts expect EPS of -$0.18 for the current quarter, with a high estimate of -$0.15 and a low estimate of -$0.23, while EPS last year was -$0.52. The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.14 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.59 and -$0.94 for the fiscal current year, implying an average EPS of -$0.74. EPS for the following year is -$0.69, with 10 analysts recommending between -$0.46 and -$1.
